Armstrong Shaw Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $221K | Hold |
|
|||||
|
2023
Q2 | $227K | Hold |
|
|||||
|
2023
Q1 | $245K | Hold |
|
|||||
|
2022
Q4 | $253K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $214K | Hold |
|
|||||
|
2021
Q3 | $206K | Hold |
|
|||||
|
2021
Q2 | $203K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $227K | Hold |
|
|||||
|
2020
Q1 | $221K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $228K | Hold |
|
|||||
|
2018
Q2 | $209K | Hold |
|
|||||
|
2018
Q1 | $222K | Hold |
|
|||||
|
2017
Q4 | $211K | Hold |
|
|||||
|
2017
Q3 | $239K | Hold |
|
|||||
|
2017
Q2 | $209K | Hold |
|
|||||
|
2017
Q1 | $200K | Hold |
|
|||||
|
2016
Q4 | $211K | Hold |
|
|||||
|
2016
Q3 | $233K | Buy |
|